Boston VA Research Institute

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Boston VA Research Institute sits in the top decile of US sponsors by registered trial count (#1,137 of 15,742 sponsors by registered trial count).

12 total trials 1 currently recruiting 11 completed early-phase tilt top decile by trial count

Boston VA Research Institute: 12 sponsored US clinical trials, 1 recruiting.

Boston VA Research Institute sponsors 12 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 11 completed. 1 of these trials are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Auditory Hallucination, with 1 trials.

Top-decile sponsor footprint

Boston VA Research Institute ranks in the top decile of sponsors by registered trial count (#1,137 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

A 90/100

11 of 11 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (100.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

12 total, page 1 of 1

RECRUITING NA

Real-time fMRI Neurofeedback in Patients With Schizophrenia and Auditory Hallucinations

NCT05299749
COMPLETED NA

Decreasing Suicide Risk Among Service Members With Posttraumatic Stress

NCT04225130
COMPLETED NA

Implementation of Strength at Home for Military Couples

NCT04517994
COMPLETED NA

Brief Treatment for Posttraumatic Stress Disorder

NCT03033602
COMPLETED NA

Interactive Spaced Education to Optimize Diabetes Care

NCT02082704
COMPLETED Phase 2

Study to Evaluate Two Lenalidomide Dose Regimens With Low Dose Dexamethasone for the Treatment Relapsed Multiple Myeloma

NCT01380106
COMPLETED NA

Strength At Home: Veterans' Program (PTSD-Focused Therapy for Anger and Relationship Conflict Among OEF/OIF Veterans)

NCT01435512
COMPLETED NA

Strength at Home Couples Program (PTSD-Focused Relationship Enhancement Therapy for Returning Veterans)

NCT00827879
COMPLETED

Development and Validation of a PTSD-Related Functional Impairment Scale

NCT00651872
COMPLETED Phase 2

Safety and Efficacy Study of Single Weekly Bortezomib in Newly Diagnosed Multiple Myeloma

NCT01090921
COMPLETED Phase 4

Antiepileptic Drugs and Osteoporotic Prevention Trial

NCT00869622
COMPLETED Phase 2

Investigation of the Enhancement of Response to Hepatitis B Vaccine by Lenalidomide in Plasma Cell Dyscrasias

NCT02041325

Phase Distribution

PhaseTrial count
Phase 2 3
Phase 4 1

Therapeutic Areas

Auditory Hallucination 1
Treatment-resistant Schizophrenia 1
Stress Disorders, Post-Traumatic 1
Schizophrenia 1

What is open in the Boston VA Research Institute pipeline

1 recruiting of 12 indexed (8% open); 11 completed (92%).

Phase mix: 1 late (III/IV) vs 3 early (I/II) (early-phase heavy).

Top condition: Auditory Hallucination (1 trial), 3 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Boston VA Research Institute: open-pipeline peers nationwide

Peers matched on 12 registered trials and 8% open enrollment, not the therapeutic-area sidebar.

Boston VA Research Institute sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 10152025 0%5%10%15%20% Total trials Recruiting share Boston VA Research InstituteAlachua Government ServicesAllergy TherapeuticsAmpio Pharmaceuticals.AngiodynamicsAcrotech BiopharmaAtlanta VA Medical CenterBeacon TherapeuticsCentrexion Therapeutics
Boston VA Research Institute sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Boston VA Research Institute sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 12 trials (± recruiting share)

Sponsors near 8% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Boston VA Research Institute page

12 registered trials is a research-attention snapshot, not an endorsement of Boston VA Research Institute or any single study.

  • 1 of Boston VA Research Institute's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Auditory Hallucination is the condition Boston VA Research Institute studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Auditory Hallucination trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Boston VA Research Institute pipeline card: 12 registered trials from official public datasets.Report a data error.